As a binary peptide, Pro-Trp could inhibit the function of dipeptidyl peptidase-IV (DPP-IV), a therapeutic target in type 2 diabetes (Nongonierma and FitzGerald, 2015). Here, DPP4 is linked to type 2 diabetes mellitus.